ERYPEG-50MG Anticancer Medicine

Name: ERYPEG-50MG Anticancer Medicine
Brand: PATHGENE PHARMA DISTRIBUTORS
Price: 2800 INR
Availability: InStock

Price 2800 INR/ Box

Get a Price/Quote

MOQ : 3 Boxes

ERYPEG-50MG Anticancer Medicine Specification

Salt Composition
Pegylated Recombinant Human Erythropoietin

Indication
Cancer-related anemia, Oncology use

Dosage Form
Injection

Enzyme Types
Recombinant protein

Feature
PEGylated for prolonged action

Ingredients
Human Erythropoietin, PEG

Application
Anticancer treatment

Ph Level
Neutral (approx. 7)

Temperature Needed For Fermentation
2-8C storage recommended

Physical Color/Texture
Clear solution

Fermentation Smell
Odorless

Enzymatic Activity
Erythropoiesis stimulation

Storage Instructions
Store in refrigerator, do not freeze

Shelf Life
18-24 months

Strength
50 mcg/0.5 ml

Sterility
Sterile solution

Treatment
Anticancer therapy supportive

Prescription
Required

Packaging Size
Box

Unit Pack
Single-use vial

Franchise Option
PCD Pharma

Subcutaneous/IV
Subcutaneous or Intravenous

ERYPEG-50MG Anticancer Medicine Trade Information

Minimum Order Quantity
3 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Boxes Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About ERYPEG-50MG Anticancer Medicine

Introducing the latest in supportive oncology treatment, ERYPEG-50MG Anticancer Medicine is a commanding solution for cancer-related anemia. Leveraging a famed PEGylated Recombinant Human Erythropoietin formulation, this unassailable injection stimulates erythropoiesis with unmatched precision. Each single-use vial contains a sterile, clear solution, ensuring optimal safety for subcutaneous or intravenous application. Unlock exclusive promotion opportunities with PCD Pharma Franchise options across India. For best efficacy, store in a refrigerator. A prescription is required. Experience ERYPEG-50MG's prolonged activity, making it a trusted ally in anticancer therapies.

Key Application Method & Usage Features

ERYPEG-50MG is administered as a sterile injection, suitable for either subcutaneous or intravenous delivery based on oncologist recommendation. The product is supplied in a single-use vial and specifically designed for the supportive treatment of cancer-related anemia. Its advanced PEGylated technology ensures prolonged activity, reducing dosage frequency. The neutral pH and odorless, clear solution provide optimal patient compatibility. Suitable for hospital and clinical settings, it must be used under a prescription and stored at 2-8C for best results.

Sample Policy & Delivery-Export Market Ready

Sample requests for ERYPEG-50MG Anticancer Medicine are accommodated with a strong focus on the export market. Samples are promptly dispatched via secure shipping options, ensuring product integrity during drop-off. We maintain a transparent policy for sample availability, supporting new partnerships. Typical delivery times for samples and bulk orders range from 7 to 10 days, leveraging robust logistics. Our tailored approach addresses both domestic and international pharma needs by offering reliable access and steadfast quality assurance.

FAQ's of ERYPEG-50MG Anticancer Medicine:

Q: How should ERYPEG-50MG be administered?

A: ERYPEG-50MG should be administered either subcutaneously or intravenously as directed by a healthcare professional. It is a single-use vial designed for sterile, precise delivery.

Q: What is the main benefit of ERYPEG-50MG in cancer therapy?

A: The primary benefit of ERYPEG-50MG is its ability to support anticancer therapy by treating cancer-related anemia, thereby improving oxygen levels and patients' overall quality of life during oncology treatment.

Q: When should ERYPEG-50MG be stored and at what temperature?

A: ERYPEG-50MG must be stored in a refrigerator at 2-8C. It is crucial not to freeze the product to maintain its efficacy and sterility.

Q: Where can I obtain ERYPEG-50MG and is a prescription required?

A: ERYPEG-50MG is available through authorized suppliers, traders, and PCD Pharma franchise partners in India. A valid prescription from a licensed healthcare professional is required for purchase.

Q: What makes ERYPEG-50MG unique compared to other anticancer support medicines?

A: ERYPEG-50MG sets itself apart by utilizing PEGylated Recombinant Human Erythropoietin, which grants it prolonged action and reduces the frequency of injections needed, enhancing patient convenience during cancer treatment.

Q: Is sample availability possible for new partners or export clients?

A: Yes, samples of ERYPEG-50MG are available for eligible partners and export market clients, with secure shipping and a clear, responsive sample policy to facilitate evaluation.

Tell us about your requirement